Federal award
KBR WYLE SERVICES, LLC
0134
Contract
Obligated and Ceiling
- Obligated (net)
- $21,399,214.05
- Ceiling (potential value, not spending)
- $23,847,566.00
- Current value
- $23,847,566.00
- Gross positive obligations
- $21,556,742.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- KBR WYLE SERVICES, LLC · KNV8E5VRLHT9
- Owner company
- KBRBasis reviewed link: a dated, evidenced ownership link.
- Reported parent
- KBR, INC. · VJ3XVZC76HT9
- Awarding agency
- Department of Defense · sub-agency 9763 · office S0107A
- Funding agency
- Department of Defense · sub-agency 5700
- Product or service (PSC)
- AZ12 · R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
- Industry (NAICS)
- 541710 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES
- PIID
- 0134
- Parent vehicle (IDV PIID)
- HC104705D4005
- Award type code
- C
- Actions
- 40 · Mar 29, 2010 to Mar 21, 2018
- Why it is listed
- gross positive obligations of $100k or more (contracts); reviewed company, $10k or more
Action History40
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Mar 21, 2018 | FY2018 | 1D | C | −$28,893.55 | |
| Apr 12, 2017 | FY2017 | 1C | C | −$67,056.62 | |
| Aug 1, 2016 | FY2016 | 1B | C | −$41,278.35 | |
| Mar 27, 2015 | FY2015 | 1A | C | −$20,289.43 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 28, 2014 | FY2014 | 35 | B | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 26, 2014 | FY2014 | 34 | B | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 27, 2013 | FY2013 | 33 | M | $111,600.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 4, 2013 | FY2013 | 32 | B | $0.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Oct 23, 2012 | FY2013 | 31 | C | $35,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jun 8, 2012 | FY2012 | 30 | C | −$10.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 8, 2012 | FY2012 | 29 | C | $228,401.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Dec 21, 2011 | FY2012 | 28 | C | $13,456.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Oct 25, 2011 | FY2012 | 27 | C | $88,941.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 23, 2011 | FY2011 | 26 | C | $396,600.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 9, 2011 | FY2011 | 25 | C | $1,799,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 30, 2011 | FY2011 | 24 | C | $500.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 18, 2011 | FY2011 | 23 | C | $130,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 6, 2011 | FY2011 | 22 | C | $500,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 29, 2011 | FY2011 | 21 | C | $4,336,364.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jun 9, 2011 | FY2011 | 20 | C | $376,788.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 31, 2011 | FY2011 | 19 | C | $357,065.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 13, 2011 | FY2011 | 18 | C | $398,529.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Apr 26, 2011 | FY2011 | 17 | C | $147,744.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 15, 2011 | FY2011 | 16 | C | $100,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 4, 2011 | FY2011 | 15 | C | $223,104.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 24, 2011 | FY2011 | 14 | C | $45,786.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 8, 2011 | FY2011 | 13 | C | $183,500.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Feb 2, 2011 | FY2011 | 12 | C | $2,150,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Nov 29, 2010 | FY2011 | 11 | C | $300,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Oct 25, 2010 | FY2011 | 10 | C | $949,345.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 28, 2010 | FY2010 | 9 | C | $89,682.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 25, 2010 | FY2010 | 8 | C | $1,200,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 20, 2010 | FY2010 | 7 | C | $416,656.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Sep 3, 2010 | FY2010 | 6 | C | $4,626,988.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Aug 17, 2010 | FY2010 | 5 | C | $30,804.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jul 19, 2010 | FY2010 | 4 | C | $376,984.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Jun 14, 2010 | FY2010 | 3 | C | $700,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 12, 2010 | FY2010 | 2 | C | $386,905.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| May 4, 2010 | FY2010 | 1 | C | $60,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
| Mar 29, 2010 | FY2010 | 0 | — | $797,000.00 | Wyle Laboratories Counted for Wyle Laboratories in company totals (direct) |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.